U.S. markets close in 5 hours 27 minutes

Skye Bioscience, Inc. (SKYE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1608-0.0002 (-0.12%)
As of 10:13AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1610
Open0.1668
BidN/A x N/A
AskN/A x N/A
Day's Range0.1600 - 0.1668
52 Week Range0.0250 - 0.2590
Volume317,898
Avg. Volume2,229,381
Market Cap59.813M
Beta (5Y Monthly)0.33
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Cannabis Industry Investor Conference: Company Executives Present June 29th & 30th
    CNW Group

    Cannabis Industry Investor Conference: Company Executives Present June 29th & 30th

    Virtual Investor Conferences in partnership with KCSA Strategic Communications and ATB Capital Markets today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 9:30 AM ET on Tuesday, June 29th.

  • Skye Bioscience Expands Clinical Advisory Board  with the Appointment of Ophthalmology Expert Dr. Miguel González-Andrades
    GlobeNewswire

    Skye Bioscience Expands Clinical Advisory Board with the Appointment of Ophthalmology Expert Dr. Miguel González-Andrades

    SAN DIEGO, CA, June 10, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has expanded its Clinical Advisory Board with the appointment of ophthalmology expert and innovator, Miguel González-Andrades, MD, PhD. "We are honored to have Dr. Miguel González-Andrades join our Clinical Advisory Board at a piv

  • CEO Presenting on the Emerging Growth Conference on June 9. Register here
    GlobeNewswire

    CEO Presenting on the Emerging Growth Conference on June 9. Register here

    Niche Companies in Technology, Biotech, Precious Metals, and more in AttendanceMIAMI, June 07, 2021 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 9th Emerging Growth Conference. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services,